These findings suggest that YTHDF2 O-GlcNAcylation is enhanced after HBV infection or in HBV-associated HCC, and modulated by intracellular O-GlcNAcylation levels. This evidence concerns the gene YTHDF2 and hepatocellular carcinoma.